## Background: The autopap 300 qc system is an automated device for the analysis of conventionally prepared cervical cytology slides. the autopap system selects an enriched population of cases for human quality control (qc) review. the device assigns a score based on the likelihood that a slide is
✦ LIBER ✦
Effectiveness of automated cervical cytology rescreening using the AutoPap® 300 QC System
✍ Scribed by Mark W. Stevens; Amanda J. Milne; Kerrie A. James; Donna Brancheau; Dayle Ellison; Leonard Kuan
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 51 KB
- Volume
- 16
- Category
- Article
- ISSN
- 8755-1039
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The AutoPap 300 QC system multicenter cl
✍
Patten, Stanley F. ;Lee, James S.�J. ;Wilbur, David C. ;Bonfiglio, Thomas A. ;Co
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 107 KB
👁 2 views
The AutoPap 300 QC system multicenter cl
✍
Patten, Stanley F. ;Lee, James S.�J. ;Wilbur, David C. ;Bonfiglio, Thomas A. ;Co
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 82 KB
👁 2 views
## RESULTS. For the historic sensitivity study, the percentages of cases present within
Effectiveness of AutoPap system location
✍
Mark W. Stevens; Amanda J. Milne; Ian H. Parkinson; Walter W. Nespolon; Nicola L
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 104 KB
Improved quality-control detection of fa
✍
C. Jay Marshall; Leslie Rowe; Joel S. Bentz
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 50 KB
👁 2 views
Federally-mandated quality control (QC) in Papanicolaou (Pap) smear testing requires rescreening of 10% of negative smears, to include cases selected randomly as well as smears from patients that may have a higher risk for developing cervical cancer based on clinical information. FDA approval of Neo